- Home
- PXS vs BOLD Comparison
PXS vs BOLD Comparison
Compare PXS & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXS
- BOLD
- Stock Information
- Founded
- PXS 2015
- BOLD 2018
- Country
- PXS Greece
- BOLD United States
- Employees
- PXS N/A
- BOLD N/A
- Industry
- PXS Marine Transportation
- BOLD
- Sector
- PXS Consumer Discretionary
- BOLD
- Exchange
- PXS Nasdaq
- BOLD Nasdaq
- Market Cap
- PXS 29.7M
- BOLD 24.4M
- IPO Year
- PXS N/A
- BOLD 2024
- Fundamental
- Price
- PXS $2.98
- BOLD $1.18
- Analyst Decision
- PXS Strong Buy
- BOLD Buy
- Analyst Count
- PXS 1
- BOLD 3
- Target Price
- PXS $10.00
- BOLD $4.00
- AVG Volume (30 Days)
- PXS 26.3K
- BOLD 276.3K
- Earning Date
- PXS 08-11-2025
- BOLD 08-11-2025
- Dividend Yield
- PXS N/A
- BOLD N/A
- EPS Growth
- PXS N/A
- BOLD N/A
- EPS
- PXS 0.63
- BOLD N/A
- Revenue
- PXS $49,342,000.00
- BOLD N/A
- Revenue This Year
- PXS N/A
- BOLD N/A
- Revenue Next Year
- PXS $31.36
- BOLD N/A
- P/E Ratio
- PXS $4.65
- BOLD N/A
- Revenue Growth
- PXS 8.07
- BOLD N/A
- 52 Week Low
- PXS $2.53
- BOLD $1.00
- 52 Week High
- PXS $5.53
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- PXS 54.92
- BOLD N/A
- Support Level
- PXS $2.76
- BOLD N/A
- Resistance Level
- PXS $3.05
- BOLD N/A
- Average True Range (ATR)
- PXS 0.08
- BOLD 0.00
- MACD
- PXS 0.01
- BOLD 0.00
- Stochastic Oscillator
- PXS 77.11
- BOLD 0.00
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.